SMC Abca1 and Abcg1 Deficiency Enhances Urinary Bladder Distension but Not Atherosclerosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39931819.
- Also identified by DOI 10.1161/CIRCRESAHA.124.325103 and PMC identifier 11867804.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Smooth muscle cells (SMCs) regulate blood flow distribution via vasoconstriction mediated by α-ARs (α-adrenergic receptors). Plasma membrane cholesterol accumulation affects α<sub>1</sub>-AR signaling and promotes loss of SMC contractile markers in vitro. ABCA1 and ABCG1 (ATP-binding cassette transporter A1 and G1) mediate cholesterol efflux to HDL (high-density lipoprotein). ABCA1/ABCG1 show high expression in medial and low expression in intimal SMCs of atherosclerotic plaques. The role of ABCA1 and ABCG1 in SMC-mediated vasoconstriction and atherogenesis remains poorly understood. We generated mice with SMC-specific <i>Abca1/Abcg1</i> deficiency on the low-density lipoprotein receptor-deficient (<i>Ldlr</i><sup><i>-</i></sup><sup><i>/</i></sup><sup><i>-</i></sup>) background by crossbreeding <i>Abca1</i><sup><i>fl/fl</i></sup><i>Abcg1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup> mice with <i>Myh11Cre</i><sup><i>ERT2</i></sup> transgenic mice. To induce SMC cholesterol accumulation and atherogenesis, we fed <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Abca1</i><sup><i>fl/fl</i></sup><i>Abcg1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup>, <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Abca1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup>, <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Abcg1</i><sup><i>fl/fl</i></sup><i>Ldlr</i><sup><i>-/-</i></sup>, and <i>Myh11Cre</i><sup><i>ERT2</i></sup><i>Ldlr</i><sup><i>-/-</i></sup> mice Western-type diet for 16 weeks. Combined <i>SMC-Abca1/Abcg1</i> deficiency increased vasoconstriction in aortic rings induced by the α<sub>1</sub>-AR agonist phenylephrine. Unexpectedly, <i>SMC-Abca1/Abcg1</i> deficiency induced urinary bladder distension by >20-fold. This was reversed by the α<sub>1</sub>-AR antagonist tamsulosin, indicating its dependence on bladder neck SMC constriction. Moreover, <i>SMC-Abca1/Abcg1</i> deficiency decreased contractile markers and increased macrophage and fibroblast markers in bladder SMCs, indicating SMC transdifferentiation. This was accompanied by free cholesterol accumulation and increased endoplasmic reticulum stress. <i>SMC-Abca1/Abcg1</i> deficiency did not induce thoracic aorta SMC transdifferentiation, presumably due to increased cholesteryl ester accumulation and no endoplasmic reticulum stress in thoracic aorta SMCs. Surprisingly, <i>SMC-Abca1/Abcg1</i> deficiency did not affect atherosclerotic lesion size or composition in the aortic root or brachiocephalic artery. We uncover a new role of SMC cholesterol efflux pathways in suppressing α<sub>1</sub>-AR-mediated vasoconstriction and bladder SMC transdifferentiation, decreasing urinary bladder distension. Our data may provide a mechanistic link for the association between urinary bladder distension and diabetes in humans, particularly because diabetes is associated with decreased cholesterol efflux. <i>SMC-Abca1/Abcg1</i> deficiency did not affect atherosclerotic lesion size or plaque composition, presumably due to low expression of <i>Abca1/Abcg1</i> in intimal SMCs.
Medical subject headings
- ATP Binding Cassette Transporter, Subfamily G, Member 1
- ATP Binding Cassette Transporter 1
- Atherosclerosis
- Myocytes, Smooth Muscle
- Urinary Bladder